| Literature DB >> 30217830 |
Thomas Musich1, Mohammad Arif Rahman1, Venkatramanan Mohanram1, Leia Miller-Novak1, Thorsten Demberg1, David J Venzon2, Barbara K Felber3, Genoveffa Franchini4, George N Pavlakis5, Marjorie Robert-Guroff6.
Abstract
Neutrophils are the most abundant leukocyte and play a critical role in the initial response to an Ag. Recently, their ability to contribute to adaptive immunity has been highlighted. We evaluated the ability of neutrophils from blood to contribute to the adaptive immune response in a preclinical rhesus macaque SIV vaccine trial. Replication-competent adenovirus-SIV recombinants induced neutrophil activation, B cell help markers, and enhanced ability to generate reactive oxygen species. Boosting with SIV vaccines (adjuvant together with ALVAC or DNA plus envelope protein) elicited significant neutrophil responses. Serum cytokine and chemokine levels induced correlated with the frequency of neutrophil subsets expressing IL-21, myeloperoxidase, and CD64. Post-SIV infection, neutrophils exhibited dysfunction, both phenotypically and functionally. B cells from protected and infected macaques cocultured with autologous polymorphonuclear cells, consisting primarily of neutrophils, were activated, underwent class switching, and produced Abs. This B cell help was not aided by addition of IL-10 and was largely contact dependent. Numerous genes associated with inflammation, Ab production, and chemotaxis were upregulated in the cocultured B cells. We conclude that immune stimulation by vaccination or antigenic exposure imparts a greater ability of neutrophils to contribute to the adaptive immune response. Harnessing this granulocytic response has the potential to improve vaccine efficacy.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30217830 PMCID: PMC6179953 DOI: 10.4049/jimmunol.1800677
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422